MNPR vs AMGN: Which Stock is Better?
Side-by-side comparison of Monopar Therapeutics and Amgen Inc in 2026
MNPR
Monopar Therapeutics
$70.32
AMGN
Amgen Inc
$331.00
Key Metrics Comparison
| Metric | MNPR | AMGN | Winner |
|---|---|---|---|
| Market Cap | $469.92M | $178.24B | AMGN |
| P/E Ratio | N/A | 25.58 | AMGN |
| EPS (TTM) | $N/A | $12.94 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.1% | AMGN |
Analyze MNPR
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MNPR or AMGN a better investment?
Comparing MNPR and AMGN: Monopar Therapeutics has a market cap of $469.92M while Amgen Inc has $178.24B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MNPR and AMGN?
MNPR (Monopar Therapeutics) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MNPR or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MNPR or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for MNPR.
Which company is more profitable: MNPR or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.1% compared to 0.0% for MNPR.
Which is the larger company: MNPR or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $178.24B compared to $469.92M for MNPR.
Should I buy MNPR or AMGN in 2026?
Both MNPR and AMGN have investment merit. MNPR trades at $70.32 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MNPR and AMGN stock?
Key differences: Market Cap ($469.92M vs $178.24B), P/E Ratio (N/A vs 25.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.1%).